Z-0673-2019 Class II Terminated

Recalled by Tosoh Bioscience Inc — Grove City, OH

FDA device recall Z-0673-2019 was initiated by Tosoh Bioscience Inc on November 30, 2018 and is designated Class II. The recall status is terminated (terminated January 14, 2021). Affected quantity: 24083 units.

Recall Details

Product Type
Devices
Report Date
January 2, 2019
Initiation Date
November 30, 2018
Termination Date
January 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24083 units

Product Description

ST AIA-PACK FT3 (FT3: Free Triiodothyronine) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Free Triiodothyronine (FT3) in human serum or heparinized plasma on specific Tosoh AIA System analyzers.

Distribution Pattern

US Nationwide

Code Information

all lots